Channels - Real‐World vs. Randomized Trial Evidence for Incretin‐Based Therapies: A Narrative Review :: FRELIP Discovery

Similar Items: Real‐World vs. Randomized Trial Evidence for Incretin‐Based Therapies: A Narrative Review

Quick Look
Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction
Quick Look
Adaptive islet biology and comprehensive incretin physiology: Emerging perspectives from Asia and Europe
Quick Look
c‐Jun N‐terminal kinase 3 as a permissive regulator of β‐cell incretin responsiveness
Quick Look
Recent advances in incretin biology and therapeutics: From glucose‐dependent insulinotropic polypeptide reappraisal to next‐generation agonists
Quick Look
Effect of cyclodextrins on cardiometabolic indices: a systematic review and meta-analysis of randomized controlled trials
Quick Look
Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney Syndrome Outcomes in Obesity: Real-World Evidence from the United Arab Emirates
Quick Look
Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials
Quick Look
Catheter-Related Superficial Venous Thrombosis of the Upper Extremity: A Narrative Review of Current Evidence, Diagnostic Pathways, and Management Strategies
Quick Look
Anagrelide for the Treatment of Essential Thrombocythemia: Real-World Observational Study in a Cohort of Colombian Patients
Quick Look
Risk factors associated with prediabetes-to-diabetes conversion in a majority-minority county: a real-world analysis
Quick Look
Real-World Effectiveness of Tirzepatide in Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study
Quick Look
Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review
Quick Look
Evaluation of Vaso-Occlusive Crises in Brazilian Sickle Cell Patients Before and After Crizanlizumab: A Real-World Study
Quick Look
Twice-Weekly Oral Iron–Folic Acid Supplementation Is an Alternative to a Daily Regimen in Pregnancy: An Open-Label, Randomized, Active-Controlled, Noninferiority Trial
Quick Look
Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
Quick Look
Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs)
Quick Look
Enhancing Hemoglobin Levels in Moderately Acute Malnourished Children Aged 6–59 Months: A Randomized Controlled Trial of a Novel Ready-to-Use Food (RUF)
Quick Look
Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece
Quick Look
Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study
Quick Look
Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response
Quick Look
Change in Effectiveness and Safety Parameters After Initiation of SGLT2 Inhibitors for Post-Transplant Diabetes Mellitus: A Real-World Observational Study
Quick Look
Relative contributions of basal vs postprandial hyperglycaemia to overall glycaemic control in newly diagnosed Chinese adults with type 2 diabetes before and after 3 months' intensive glucose‐lowering therapy
Quick Look
Real-World Glucometric Outcomes of the MiniMed 780G Advanced Hybrid Closed-Loop System in Users with Type 1 Diabetes in Spain
Quick Look
Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication